AlphAIAlphAI — Financial news for AI agents
investing.com$AFRM

Scotiabank raises Affirm stock price target to $97 on growth outlook

Scotiabank raised its price target on Affirm (AFRM) to $97 from $95, maintaining a Sector Outperform rating. The fintech company reported 30% gross merchandise volume growth, a 4.3% transaction cost take rate, and raised its fiscal 2027 growth floor to 30%. Affirm's Q1 2027 earnings beat expectations with $0.47 EPS on $1.26B revenue. Management noted increased allowance rates and delinquencies but highlighted better loan sale pricing.

Original reporting
investing.com
Published Nov 6, 2026, 1:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 1:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$AFRM
Bullish
high confidence
Mentioned
$AFRM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AFRMBullishHigh
01

Why it matters

The combination of earnings beat and upgraded price target provides a fresh catalyst for short‑term price movement.

02

Market read

Affirm's earnings beat and higher price target create a clear trading opportunity.

03

What to watch

Cost of funds increase and reserve buildup may pressure margins despite earnings beat.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Scotiabank raised its price target on Affirm to $97, citing growth outlook and recent earnings beat.

Company-level read

Ticker impact

$AFRMBullishHigh confidence
Context

Affirm reported fiscal Q1 2027 earnings beating estimates with EPS $0.47 vs $0.38 forecast and revenue $1.26B vs $1.21B forecast.

Expected impact

likely upward pressure as investors price in the earnings beat and higher price target.

Evidence & confidence

The surprise earnings beat and analyst price‑target raise are fresh, material information that can move the stock today.

Market effects

Sector

Fintech sector may see broader optimism from a leading BNPL player beating expectations.

Regional

U.S. market sentiment could improve for consumer finance stocks.

Global

Limited to U.S. fintech; no immediate global macro effect.

Counterpoint

What could challenge this read

Higher credit losses and rising delinquencies could temper upside.

Key entities

  • company
    Affirm Holdings

    U.S. fintech offering buy‑now‑pay‑later services.

  • financial_institution
    Scotiabank

    Analyst raising price target on Affirm.

Read at source← All news

Related articles

$AFRMHighAI 8/10

Affirm Posts Its Best Quarter Ever as Visa and Mastercard Wobble

Affirm reported fiscal Q1 2027 earnings with GAAP EPS of $0.47, beating estimates, and revenue of $1.26B, up 35% YoY. Gross merchandise volume rose 34% to $14.4B. The company raised its full-year outlook, citing strong growth in its card services and active users. Affirm's performance contrasts with declines in Visa and Mastercard shares amid stablecoin concerns.

startupfortune.com
$AFRMMed

Affirm (AFRM) Q1 2027 Earnings Call Transcript

Affirm (AFRM) executives discussed growth prospects, funding costs, and agentic shopping during Q1 2027 earnings call. Max Levchin expects 30%+ growth for a long time, citing low e-commerce penetration. Robert O'Hare confirmed a 30% growth floor for the year. Levchin also highlighted Affirm's focus on agentic shopping, emphasizing personalized transaction pricing. Funding costs rose 27 bps quarter-over-quarter but remain down year-on-year, with 70% of on-balance sheet funding fixed-rate.

finance.yahoo.com
$AFRMMed

Piper Sandler lowers Affirm stock price target to $105 on valuation

Piper Sandler cut its price target on Affirm (AFRM) to $105 from $115, citing valuation changes, while raising its fiscal 2027 EPS estimate to $1.92. Affirm's Q1 results beat expectations with $1.26B revenue and $0.47 EPS, but shares fell 8% after-hours. Analysts note potential upside, with revenue growth of 32% and predicted profitability. Other analysts raised targets to $97 (Scotiabank) and $100 (Needham).

investing.com
$AFRMMed

Needham reiterates Affirm stock rating citing strong growth

Needham reiterated a Buy rating and $100 price target on Affirm (AFRM) after Q1 results beat estimates. Revenue rose 32% to $4.26B, with earnings of $5.53 per share. Affirm Card showed strong growth, but shares fell due to credit cost concerns. InvestingPro notes volatility and potential undervaluation. Q1 2027 earnings of $0.47 per share on $1.26B revenue exceeded expectations, with a 34% GMV increase.

investing.com